N
SPPI

Nuveen’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Nuveen’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-451,726
Closed -$520K – 3571
2022
Q1 		$520K Buy
451,726
+4,997
+1% +$4.6K ﹤0.01% 3004
2021
Q4 		$599K Sell
446,729
-35,619
-7% -$63.7K ﹤0.01% 3022
2021
Q3 		$1.17M Sell
482,348
-168
-0% -$459 ﹤0.01% 2932
2021
Q2 		$1.81M Sell
482,516
-149,616
-24% -$520K ﹤0.01% 2761
2021
Q1 		$2.06M Sell
632,132
-11,432
-2% -$41K ﹤0.01% 2604
2020
Q4 		$2.19M Buy
643,564
+2,607
+0.4% +$10.7K ﹤0.01% 2464
2020
Q3 		$2.62M Buy
640,957
+89,772
+16% +$341K ﹤0.01% 2248
2020
Q2 		$4.82M Buy
551,185
+91,996
+20% +$268K ﹤0.01% 1916
2020
Q1 		$1.07M Sell
459,189
-116,012
-20% -$318K ﹤0.01% 2492
2019
Q4 		$2.09M Buy
575,201
+106,487
+23% +$860K ﹤0.01% 2403
2019
Q3 		$3.89M Sell
468,714
-313,207
-40% -$2.53M ﹤0.01% 2093
2019
Q2 		$6.73M Buy
+781,921
New +$6.99M ﹤0.01% 1831

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Nuveen's SPPI Position: Q2 2022 in Review

Nuveen sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 451,726 shares — an estimated $520K sold.

Nuveen first reported a position in SPPI in Q2 2019 and held it in 12 quarters. The position peaked at $6.73M in Q2 2019. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • Nuveen reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 451,726 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $520K.
  • Nuveen first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 12 quarters.
  • Nuveen's Spectrum Pharmaceuticals Inc position peaked at $6.73M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.